Novel Microdevices Joins Baltimore’s LaunchPort™ Medtech Venture Center
Share Article BALTIMORE (PRWEB) February 26, 2021 The LaunchPort™ announced today that Novel Microdevices (http://www.noveldx.com) has moved to their Medtech venture center in Port Covington, Baltimore, and has established The LaunchPort™ as its primary location for their GMP development efforts.
Novel Microdevices has established engineering prototyping, clean room operations, materials handling, and shop capabilities in separate modules within the Center that are allowing them to develop and validate the various elements of their Good Manufacturing Processes (GMP). The Company has received over $2M in NIH funding and is in the process of securing additional contracts for the delivery of diagnostics of sexually transmitted infections. The Company also recently received funding from NIH’s RADx program to explore the possible app